TickerFactsScreenerDevelopers

Acrivon Therapeutics, Inc. (ACRV) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$13.98M2022: -$30.12M2023: -$42.64M2024: -$65.67M2025: -$63.66M-$63.66M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$63.66M+3.1%
2024-$65.67M-54.0%
2023-$42.64M-41.6%
2022-$30.12M-115.4%
2021-$13.98M—